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Objectives

After completing this article, readers should be able to:

1. Review the discoveries and advances in teratology, genetics, toxicology, and clinical
teratology counseling in the past 50 years.
2. Explain the changes that have occurred in some basic principles of teratology.
3. List the drugs, chemicals, infections, and other environmental agents that may harm
the developing embryo.
4. Explain how congenital malformations can be prevented and how to manage
pregnancies in which the embryo has a congenital malformation.
5. Delineate the principles involved in evaluating the risks and effects of environmental
toxicants and know how to evaluate the potential risks of a specific exposure.
6. Discuss how to evaluate whether a child’s congenital malformation is caused by an
environmental exposure or other mechanism.

commercial
product/device.

Introduction
During the first half of the 20th century, the field of teratology (the study of birth defects)
was represented sparsely in the medical literature. Pediatricians who graduated from
medical school in the 1950s were taught that the correct number of human chromosomes
was 48, until the number was reported accurately as 46 by Tijo and Levan in 1956. (1)
Gregg had described the teratogenicity of rubella virus infection during pregnancy in
1941. (2) The teratogenic risk of the folic acid antagonists (aminopterin) was established
in humans, (3)(4) and experimental studies indicated that nutritional deficiencies could
produce congenital malformations (CMs) in animals. (5)(6)(7)
In the 1950s, teratologists were aware that only a small percentage of birth defects were
caused by drugs, chemicals, and physical agents. (5) By 2007, further information
confirmed the viewpoint that birth defects caused by drugs, chemicals, and physical agents
account for a small but significant percentage of total birth defects (Table 1). (6)(7)(8)(9)
However, avoiding teratogenic drugs and chemicals or reducing teratogenic maternal
disease states has a major impact on an individual pregnancy and family.
Reproductive problems encompass a multiplicity of diseases, including sterility, infertility, spontaneous abortion (miscarriage), stillbirth, congenital malformations (due to
environmental or hereditary causes), fetal growth restriction, and prematurity. (6)(7)
(8)(9) Because these clinical problems occur commonly in the general population,
environmental causes are not always easy to corroborate (Table 2). Severe CMs occur in 3%
of births.
According to the Centers for Disease Control and Prevention (CDC), severe CMs
include those birth defects that cause death, hospitalization, or intellectual disability;
necessitate significant or repeated surgical procedures; are disfiguring; or interfere with
physical performance. Each year in the United States, 120,000 infants are born with
severe birth defects. Genetic diseases occur in approximately 11% of births. Spontaneous
mutations account for less than 2% to 3% of genetic diseases (Table 1). Therefore,
mutations induced from preconception exposures to environmental mutagens are
difficult endpoints to document (Table 2). Birth defects account for 440,000 deaths
among children each year in developing nations, representing 3.7% of the deaths in
children. In the United States, 25% of infant deaths are due to lethal CMs.
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Table 1.

Reproductive and Developmental Effects

Condition
Immunologically and clinically diagnosed spontaneous
abortions per million conceptions (20% have lethal
malformations or chromosome abnormalities that
cause spontaneous abortion before the first month
of gestation [first missed menstrual period])
Clinically recognized spontaneous abortions per
million clinically recognized pregnancies
Spontaneous abortion after the first missed menstrual
period
Genetic diseases per million births
Multifactorial or polygenic genetic environmental
interactions
Dominantly inherited disease
Autosomal recessive and sex-linked genetic disease
Cytogenetic (chromosomal abnormalities)
New mutations in the developing ova or sperm
before conception
Major malformations (genetic, unknown, environmental)
Prematurity (Ireland, 55,000; United States, 124,000)
Fetal growth restriction
Stillbirths (>20 wk)
Infertility
Modified from Brent. (7)

Pediatricians and pediatric subspecialists cannot ignore the medical problems associated with CMs because
they are the leading cause of death in infancy (1 to 12
months of age). (6)(7) They are the fifth leading cause of
death from disease in the entire population and are
responsible for a large number of hospitalizations. Although clinicians who care for pregnant women play a
very important role in the effort to prevent CMs, pediatricians also can contribute to the preventive effort and
counseling of families in their practices who have a child
born with a CM.

Advances in Teratology and Genetics During
the Last Half of the 20th Century
During the past 50 years, substantial discoveries and
advances have been made in teratology, genetics, toxicology, and clinical teratology counseling (Table 3). The
number of genetic diseases catalogued in the post-World
War II period was approximately 1,500. (10)(11) In the
year 2006, the Human Genome Project identified more
than 6,000 single-gene genetic abnormalities, many of
which manifest as CMs. (12) Also, a large number of
chromosome abnormalities and complex or polygenic
genetic diseases involve multiple genetic loci (eg, diabetes and obesity).

The field of prenatal diagnosis,
using ultrasonography, karyotyping, biochemical studies, and moFrequency
lecular biology studies, has ex350,000
panded the ability to diagnose
anatomic malformations, metabolic
diseases, and genetic diseases in the
embryo and to determine the cause
150,000
of many birth defects that previously were listed in the unknown
category (Tables 1 and 2). The abil110,000
ity to determine the cause of a
90,000
child’s birth defect has improved, as
well as the ability to inform the
10,000
family about the risk of recurrence.
1,200
(11)(13)(14)(15)(16)(17)(18)
5,000
3,000
The topic of interruption of
pregnancy is controversial in many
30,000
countries and continues to be de69,000
bated both politically and ethically,
30,000
but it offers the opportunity to
4,000 to 20,900
7% of couples
eliminate nonviable or severely malformed embryos early in pregnancy. Physicians should understand that the family makes the
decision on how to manage pregnancies affected with serious abnormalities; the physician’s role is as an educator who defines the problem and
prognosis. Nature frequently preempts politics and ethics, with most early spontaneous abortions occurring in
embryos that have either karyotype abnormalities or
serious anatomic malformations. Another reason that
interruption of pregnancy is controversial is because the
procedure does not prevent CMs; rather, it eliminates
severely malformed embryos very early in pregnancy.
Abnormal pregnancies can be diagnosed early in gestation through maternal serum biochemical markers, and
ultrasonography, amniocentesis, and chorionic villous
sampling can aid in the diagnosis of very serious or fatal
abnormalities early in pregnancy.
Discovery of new teratogens, such as the angiotensinconverting enzyme inhibitors and misoprostol, have
taught clinicians to be prepared to accept new principles
in teratology that are discovered when new teratogens
are identified that do not follow the “old” rules, such as
the belief that severe anatomic CMs can be induced only
during early organogenesis. (19)(20)(21)(22)(23)(24)
(25)(26)(27)(28)(29)(30) Microcephaly, intellectual
disability, growth restriction, and vascular disruptive
phenomena can be induced by embryotoxic exposures in
the second and third trimesters (Table 4).
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●

The pediatrician may attend a
delivery of a malformed child
and subsequently be involved
in litigation as a fact witness or
Percent of
defendant.
Suspected Cause
Total
● Mothers of pediatric patients
Unknown
65
may become pregnant and
Polygenic
ask their child’s pediatrician
Multifactorial (gene-environment interactions)
about the risk of medications,
Spontaneous errors of development
immunizations, or other enviSynergistic interactions of teratogens?
Genetic
15 to 25
ronmental exposures that may
Autosomal and sex-linked inherited genetic disease
be prescribed during pregCytogenetic (chromosomal abnormalities)
nancy.
New mutations
●
Pediatricians should encourEnvironmental
10
age teenagers to receive the
Maternal conditions: alcoholism, diabetes, endocrinopathies,
4
phenylketonuria, smoking and nicotine, starvation,
human papillomavirus vaccine
nutritional deficits
and encourage all women of
Infectious agents: rubella, toxoplasmosis, syphilis, herpes simplex,
3
reproductive age to take 400
cytomegalovirus, varicella-zoster, Venezuelan equine encephalitis,
g of folic acid and 6 g of
parvovirus B19
vitamin B-12 each day to reMechanical problems (deformations): amniotic band constrictions,
1 to 2
umbilical cord constraint, disparity in uterine size and uterine
duce the risk of neural tube
contents
defects. (15)
Chemicals, prescription drugs, high-dose ionizing radiation,
2 to 3
Pediatricians
have a multitude of
hyperthermia
educational aids to assist in their
Modified from Brent. (7)
evaluations, including consultations with clinical teratologists
Environmental Causes of Developmental and
and geneticists, the medical literature, OMIM (the
Reproductive Effects
web site for the Online Mendelian Inheritance of Man
Obstetricians and perinatologists obviously must be fasupported by the National Institutes of Health) (11)
miliar with drugs, chemicals, infections, and other enviand TERIS (the web site of the Teratogen Information
ronmental agents (Table 4) that may harm the developServices located at the University of Washington),
ing embryos of their pregnant patients, but this an area of
(17) and publications that review the field of CMs.
importance to pediatricians as well. A comprehensive
(12)(13)(14)(16)(18)(19)(20)(21)(22)(23)(24)(25)
textbook chapter on the environmental causes of birth
(26)(27)(28)(29)(30)
defects may be helpful to pediatricians who wish to have
Prevention of Congenital Malformations and
more extensive information about teratogenic agents.
Management of Affected Pregnancies
(14) Pediatricians may encounter several specific situaSome of the discoveries pertaining to the causes of in
tions related to birth defects:
● Because teenagers under the care of a pediatrician
utero developmental problems have been translated into
do get pregnant, it is important to consider the
preventive measures (Table 5) The implementation of all
possibility of pregnancy when prescribing medicaof these measures could reduce the prevalence of birth
tions for teenage patients. In particular, the admindefects and other developmental problems. The Centers
istration of retinoids (isotretinoin), anticonvulfor Disease Control and Prevention (CDC) has initiated
sants, and vaccines may place the pediatrician at
a campaign to emphasize that some birth defects can
legal risk. (31)
be prevented. (32) A fact sheet from this campaign is
● Some of pediatric patients have CMs or other depublished in the online version of this article (see data
velopmental effects and the parents may ask the
supplement). The National Academy of Sciences has
pediatrician about the cause of their child’s medical
published a report addressing the problem of reducing
problems. The pediatrician should be prepared to
birth defects in developing nations. (33) Individual teraanswer the questions or refer the family to a clinical
tologists have been attempting to accomplish this goal
teratologist or geneticist.
for years with regard to the prevention of neural tube
Table 2.
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a significant proportion of the population is not receiving adequate
Table 3.
folic acid and vitamin B-12 to
prevent all folic acid-preventable
NTDs.
Tens of thousands of children
• Correct number of chromosomes: 46 (1)
are born each year with folic acid• Karyotyping and the discovery of chromosomal diseases
preventable NTDs. The United
• Advances in molecular biology
States spends $200,000,000 each
• Development of the principles of teratology
• Improvement in the techniques of counseling parents about causes and risks
year to eradicate poliomyelitis
• Increasing number of identified genetic diseases that are responsible for
through an excellent program of
congenital malformations and developmental problems
polio immunization, and frequent
• Continuing discovery of new teratogens (3 in 1950 to more than 52 in 2008)
epidemiologic monitoring of the
• Invention and application of computed tomography scans, magnetic resonance
incidence of poliomyelitis provides
imaging, and diagnostic ultrasonography
• Development and implementation of the administration of rubella vaccination
data on the changing incidence of
• Folic acid supplementation to wheat grains and the prevention of folic acidthe disease (personal communicapreventable neural tube defects
tion, G.P. Oakley Jr, 2010). The
• Creation of the Online Mendelian Inheritance in Man program on the internet
program has reduced the incidence
for diagnosing genetic diseases (10)(11)
of polio to 1,000 cases per year.
• Introduction of fetal therapy and accompanying controversies
• Improvement in the control and management of diabetes during pregnancy
Polio may never be eliminated be• The Human Genome Project (12)
cause of subclinical infections and
• Determination of the vulnerability of the embryo at different stages of
the possibility of new mutated
development
strains, in contrast with smallpox.
• Fetal therapy and intervention based on the wishes of the parents after
The CDC has been provided with a
thorough discussion of the risks and benefits
budget of $5,000,000 for the prevention of the approximate 200,000
defects (NTDs) through folic acid supplementation.
folic acid-preventable NTDs worldwide. Thus, the United
(15)(34)(35)(36)(37)(38)(39)(40)
States is spending $200,000 for each case of polio prevented and $25 for each NTD case prevented.

Advances in Teratology, Molecular
Biology, Epidemiology, Clinical Teratology,
and Genetics

Folic Acid
Folic acid supplementation of grain was recommended
following the 1991 publication of the controlled study
performed by the Medical Research Council that demonstrated that folic acid could prevent NTDs. (35) Based
on this and other publications, the United States Food
and Drug Administration (FDA) recommended that folic acid be added to grains, and the grain industry complied. Although only 50% of the amount recommended
by the Institute of Medicine was added to the grain
supply, the incidence of NTDs was reduced. Proponents
of doubling the amount of folic acid in the grains claimed
that all the preventable NTDs were not being prevented.
(15)(36)(37)(38)(39)(40) The situation is worse in the
rest of the world because only 10% of the world’s population is receiving additional folic acid in the grain supply,
which suggests that 90% of the populations in the developing nations are not receiving adequate amounts of
folic acid. Only a small proportion of women take 400 g
of folic acid and 6 to 8 g of vitamin B-12 in a multivitamin each day. Because of inadequate supplementation
of grains, especially corn meal, even in the United States,

Iodine Deficiencies
Iodine deficiency as a cause of intellectual disability and
goiter was recognized by a Swiss physician almost 200
years ago, (41) but the Swiss Academy rejected the
findings. One hundred years elapsed before iodine deficiency as a clinical entity was supported by other scientists. (41) In many parts of the world, the soil is deficient
in iodine, and goiters, hypothyroidism, and cretinism
have been endemic. (42)(43) In 2007, the World Health
Organization estimated that 2 billion individuals had
insufficient iodine intake. Iodine deficiency is considered
the single greatest preventable cause of intellectual disability. These problems were reduced or eliminated in
the United States with the addition of sodium iodide to
salt, referred to as “iodized salt.” However, iodide deficiency may return to the United States with the emphasis
on reducing salt intake to reduce the incidence of hypertension, especially if restaurants and prepared food product manufacturers also reduce the amount of salt in their
products. The FDA and some pharmaceutical companies
are considering the addition of potassium iodide or so-
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Environmental Agents or Milieus That May Increase the Risk or
Be Associated With an Increased Risk of Reproductive or
Developmental Effects

Table 4.

Agents
• Alcohol (ethyl alcohol)
• Aminopterin, methotrexate
• Androgens
• Angiotensin-converting enzyme inhibitors
• Angiotensin II receptor blocker (sartans)
• Antidepressants (selective serotonin reuptake inhibitors)
• Antituberculosis therapy
• Caffeine
• Carbamazepine
• Cocaine
• Cobalt used in hematinic vitamin preparation
• Coumarin derivatives
• Cyclophosphamide
• Diethylstilbestrol
• Diphenylhydantoin
• Lithium carbonate (salts)
• Methimazole
• Minoxidil
• Misoprostol
• Mycophenolate mofetil
• Penicillamine (D-penicillamine)
• Phenobarbital
• Progestational drugs
• Retinoids administered systemically (isotretinoin,
etretinate)
• Retinoids administered topically
• Streptomycin
• Tetracyclines
• Thalidomide
• Trimethoprim
• Valproic acid
• Vitamin D
Procedures
• Chorionic villous sampling
• Insulin shock therapy
• Methylene blue intrauterine instillation
• Radiation: radioactive isotopes (radionuclides)
• Radiation: external diagnostic or therapeutic ionizing
radiation
• Ultrasonography

Environmental Exposures
• Carbon monoxide (maternal) poisoning
• Electromagnetic fields
• Environmental chemicals (eg, dioxin, Agent Orange,
phthalates, bisphenol A)
• Lead
• Methyl and ethyl mercury “poisoning”
• Polychlorinated biphenyls
• Smoking tobacco and absorption of nicotine and
other products contained in tobacco
• Toluene and gasoline inhalation addiction
Environmental Conditions
• Diabetes
• Endocrinopathy
• Hyperthermia
• Folic acid and vitamin B-12 (risk of deficiency)
• Iodide deficiency
• Phenylketonuria (maternal)
• Mechanical problems in utero
• Nutritional deprivation
• Obesity
• Thyroid hypofunction (iodine deficiency,
I-131 administration, antithyroid drugs)
• Vitamin A excess and deficiency
Infectious Diseases
• Fetal infections
• Cytomegalovirus
• Herpes simplex 1 and 2
• Human immunodeficiency virus
• Parvovirus B19
• Rubella virus
• Rubella vaccine
• Syphilis
• Toxoplasma
• Varicella-zoster
• Venezuelan equine virus encephalitis

Reproductive or developmental effects include congenital malformations, miscarriage, growth restriction, and neurobehavioral effects. Published articles
addressing these reproductive or developmental agents can be found on the TERIS web site, (17) which provides the risk estimate for each agent and the
quality of the available literature. Other drugs, chemicals, and environmental situations (eg, obesity) that may affect the embryo/fetus can be obtained from
the TERIS web site and Shepard (now on the TERIS web site).
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arly analysis required for a differential diagnosis of any compliTable 5.
cated clinical problem. If the
mother of a malformed infant had
some type of exposure during
1. Rubella vaccination
pregnancy, such as a diagnostic
2. Folic acid (400 g/day), vitamin B-12 supplementation (6 g/day)
3. Supplementation of iodine to deficient populations
radiologic examination or medi4. Diagnosis and management of maternal hypothyroidism
cation, the consulting physician
5. Meticulous diabetic control and eventually the prevention or cure of diabetes
should not support or suggest the
6. Obesity control (reduces the risk of birth defects and decreases the risk of
possibility of a causal relationship
developing diabetes)
before performing a complete
7. Human immunodeficiency virus screening and treatment
8. Vaccination with group B Streptococcus vaccine
evaluation. Similarly, if a pregnant
9. Maternal phenylalanine management for phenylketonuria
woman who has not yet delivered
10. Management or discontinuation of oral anticoagulants, anticonvulsants,
had some type of exposure during
retinoids, thalidomide, and all known teratogens
pregnancy, the consulting physi11. Recognition that that new teratogens can be represented in the next new
cian should not support or sugdrug or chemical: angiotensin-converting enzyme inhibitors, angiotensin II
receptor blockers, mycophenolate
gest the possibility that the fetus is
12. Cessation of maternal smoking and alcohol ingestion
at increased risk before perform13. Immunization against known teratogenic infections (botulin toxin vaccine for
ing a complete evaluation.
the pregnant mother to prevent infant botulism)
Many articles and books can as14. Reducing the incidence of multiple births following in vitro fertilization
sist
the physician with the clinical
15. Counseling older women and men about the increased risk of Down syndrome
and other genetically determined diseases in older couples contemplating
evaluation, although general pedipregnancy
atric training programs do not usu16. Screening for chromosome abnormalities and genetic disease: amniocentesis,
ally prepare generalists to perform
chorionic villous sampling, maternal serum monitoring, and ultrasonographic
sophisticated genetic or teratology
monitoring to diagnose identifiable genetic diseases, karyotype abnormalities,
counseling. (11)(24)(25)(26)(27)
and serious birth defects to inform the parents about their risks and options
(28)(29)(30) In addition to performing the usual history and
dium iodide to multivitamin preparations. Young infants
physical evaluation, the physician must obtain inforshould ingest 40 g/day of iodine, and women require
mation about the nature, magnitude, and timing of
150 g/day during pregnancy. (44)
the exposure. The physical examination should include descriptive and quantitative information about
the physical characteristics of the child. Although
Down Syndrome
some growth measurements are routine, many meaThe incidence of Down syndrome in the United States
surements used by specialized counselors are not part
has increased significantly since 1980. In 1980, the prevof the usual physical examination, such as palpebral
alence was 0.99 per 1,000 births, with 3,579 affected
fissure size, ear length, intercanthal distances, total
newborns in the United States. In 2003, the prevalence
height-to-trunk ratio, and many other findings. Imof Down syndrome was 1.5 per 1,000 births, with 6,134
portant physical variations in facial, hand, and foot
affected newborns, reflecting a 71% increase in numbers
structure as well as other anatomic structures may be
and 52% increase in prevalence. (45) In 1980, 4.57%
suggestive of known syndromes, either teratologic or
births were in women older than 35 years. In 2003,
genetic.
14.04% of births occurred in women older than 35 years.
The increase in pregnancies in older women related to
women postponing marriage and pregnancy for educaEvaluating the Potential Risks of
tion or professional reasons make this a difficult problem
Environmental Exposure
to solve.
Most consultations involving pregnancy exposures conclude that the exposure does not change the reproducClinical Evaluation
tive risks in that pregnancy. In many instances, the availThe physician responding to the question, “What caused
able information is so vague that the counselor cannot
my child’s birth defect?” should perform the same scholreach a definitive conclusion about the magnitude of the

Prevention of Congenital Malformation
and Perinatal Disease
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risk. Information that is necessary for this evaluation
includes:
●
●
●

●

●

●

●

●

What was the nature of the exposure?
Is the exposure agent identifiable? If the agent is identifiable, has it been identified definitively as a reproductive toxin causing a recognized constellation of malformations or other reproductive effects?
When did the exposure occur during embryonic and
fetal development?
If the agent is known to produce reproductive toxic
effects, was the exposure above or below the threshold
for these effects?
Were there other significant environmental exposures
or medical problems during the pregnancy?
Is this a wanted pregnancy or is the family ambivalent
about carrying this baby to term?
What is the medical and reproductive history of the
mother with regard to previous pregnancies and the
reproductive history of the family lineage?

Teratology Principles
A number of important clinical rules are important when
determining the cause of a patient’s congenital malformations. (6)(7)(9)(14)
●

●

●

No teratogenic agent should be described qualitatively
as a teratogen because a teratogenic exposure includes
not only the agent, but also the dose and the time in
pregnancy when the exposure has the potential for
causing CMs and other developmental effects.
Even agents that have been demonstrated to result in
malformations cannot produce every type of malformation. Known teratogens may be implicated presumptively by the spectrum of malformations they
produce (the syndrome that describes the clinical manifestations of the teratogenic agent). However, different teratogenic agents may affect the fetus with a
similar spectrum of malformations, thus preventing the
physician from providing the family with a definitive
diagnosis. Some teratogenic syndromes mimic genetic
syndromes, such as thalidomide effects mimicking
Holt-Oran syndrome. It is easier to exclude an agent as
a cause of birth defects than to conclude definitively
that it was responsible for birth defects because of the
existence of genocopies of some teratogenic syndromes.
The dose is a crucial component when evaluating the
risk of exposures. Teratogenic agents follow a toxicologic dose-response curve, which means that each teratogen has a threshold dose, below which there is no risk

●

●

preventing congenital malformations

of teratogenesis, no matter when in pregnancy the
exposure occurred.
The evaluation of a child born with CMs cannot be
performed adequately unless it is approached with the
same scholarship and intensity as the evaluation of any
other complicated medical problem.
Each physician must recognize the consequences of
providing erroneous information on reproductive
risks to pregnant women exposed to drugs and
chemicals during pregnancy or alleging that a child’s
malformations are due to an environmental agent
without performing a complete and scholarly evaluation.
Reproductive problems alarm the public, the press,
and some scientists to a greater degree than most
other diseases. In fact, severely malformed children
are disquieting to clinicians, especially those inexperienced in dealing with these problems. No physician
is comfortable informing a family that their child was
born without arms and legs. The objective evaluation of environmental causes of reproductive diseases is clouded by the emotional climate that surrounds these diseases, resulting in the expression of
partisan positions that either diminish or magnify the
environmental risks. Such nonobjective opinions can
be expressed by scientists, the public, or the press.
(31) Every physician must be aware of the emotionally charged situation when a family has a child born
with a birth defect.

Environmental Exposures Occurring During
Pregnancy
After obtaining all this information, the counselor is in a
position to provide the family with an estimate of the
reproductive risks of the exposure. Following are some
examples of consultations that have been referred to our
clinical teratology service:
Patient 1. A 33-year-old mother of two was diagnosed
with breast cancer, and her only treatment was radiation
therapy to the left breast. She had a very good prognosis
because the disease was only in the breast and there were no
positive axillary lymph nodes. She underwent 6 weeks of
radiation therapy. In the third week of therapy, it was
determined that she was 8 weeks postconception. The oncologist and radiation therapist suggested that the pregnancy
should be interrupted. The woman continued her radiation
therapy to her breast but refused the interruption of her
pregnancy and requested another opinion. The radiation
therapist informed our office that the mother was receiving
2.25 Gy/day to her left breast. The health physicist calculated the fetal exposure to be 0.017 Gy for each therapy
Pediatrics in Review Vol.32 No.10 October 2011 417
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session, which indicated that the fetus would receive 0.425
Gy (42.5 rads) during 25 radiation sessions over a period of
5 weeks. The mother asked to speak with the physician
directly because she wanted the answers to several questions:
1) “Could the child be malformed?” Answer: The fetus had
a 3% risk of malformation and a 15% of miscarriage
because that is the background risk for all women. The risks
would not be increased by the radiation exposure because of
the protracted exposure over a 5-week period. 2) “Could the
child have growth restriction?” Answer: Approximately 4%
to 10% of children experience growth restriction, and it is
unlikely that the protracted radiation exposure would have
a marked effect on growth, but it is possible. 3) “Could my
child be normal?” There is a greater than 90% chance that
the child will be normal. This mother told her physicians
that she was not interrupting the pregnancy. She delivered
a 6 lb 11oz boy who was physically healthy after a careful
evaluation.
Patient 2. A 34-year-old pregnant laboratory worker
dropped and broke a reaction vessel containing a mixture
of chemical reagents. After cleaning the floor with paper
towels, she became concerned about the potential harmful
effects of the exposure. She was in the sixth week of her
pregnancy, which means that the embryo was in the period
of organogenesis. The chemicals in the spill were tetrahydrofuran (70%,) pyridine (20%), and iodine (1%). It was not
possible to estimate the quantitative exposure to the agents,
but the laboratory worker experienced no symptoms from the
exposure. The pregnancy was planned and wanted. Although iodine can interfere with thyroid development, the
exposure in this situation would be inconsequential because
the thyroid gland is not yet present in the fetus. The other
two compounds have not been evaluated in epidemiologic
studies of pregnant women. No other exposure to reproductive toxins occurred in this pregnancy, and the family
history for CMs was negative. The woman was advised that
this exposure was very unlikely to increase her teratogenic
risk because the exposures to the embryo would be extremely
low. She was also told that she still faced the background
risks for birth defects and miscarriage. Therefore, her reproductive risks should be the same as the risks for the general
population. The infant was healthy at birth and weighed
3,170 g.
Patient 3. A 26-year-old woman was in an automobile crash in her tenth week of pregnancy and sustained a
severe concussion. Although she did not convulse postinjury, the treating neurosurgeon prescribed 300 mg of
diphenylhydantoin during her first 24 hours in the hospital. She recovered from the injury without any sequelae, but her primary physician was concerned that she
had received an anticonvulsant associated with a tera-

togenic syndrome. No other exposure to reproductive
toxins occurred in this pregnancy, and the family history
for CMs was negative, except for an uncle who was born
with neurofibromatosis. The primary physician requested
a consultation about the teratogenic risk. Although diphenylhydantoin administered chronically throughout
pregnancy has been associated with a low incidence of
characteristic facial dysmorphogenesis, reduced mentation, cleft palate, and digital hypoplasia, no data indicate that 1 day of therapy would cause any of the features
of this syndrome. Furthermore, the lip and palate have
completed their development by the 10th week of gestation. The mother chose to continue her wanted pregnancy
and delivered a healthy 3,370-g boy at term.
Patient 4. A 25-year-old woman was seen in the emergency service of her local hospital because of nausea, vomiting, and diarrhea. She had just returned from a cruise on
which a number of the passengers became ill with similar
symptoms. The emergency department physician ordered a
pregnancy test followed by a radiograph of the abdomen
because there was evidence of peritoneal irritation. Results
of both studies were negative. However, 1 week later, the
woman missed her menstrual period, and 2 weeks later, her
pregnancy test was positive. Her obstetrician was concerned
because she had been exposed to a radiologic procedure at a
time when she was pregnant and referred her for counseling
after obtaining ultrasonography that indicated that the
embryo was approximately 7 days postconception at the time
of the radiologic examination. The patient advised the
counselor that she was ambivalent about the pregnancy
because of the “dangers” of the radiographs to her embryo.
The estimated exposure to the embryo was less than 500
mrad (0.005 Sv), which is far below the exposure known to
affect the developing embryo. Further, the embryo was exposed during the first 2 weeks postconception (all or none
period), a time that is less likely to increase the risk of
teratogenesis, even if the exposure had been much higher.
After evaluation of the family history and after she received
counseling about the risks of the radiograph, the prospective
mother decided to continue the pregnancy. She delivered a
3,150-g healthy baby.

Evaluating the Cause of a Congenital
Malformation
Patient 5. A mother of a 30-year-old man born in the
Azores in 1960 who had congenital absence of the right
leg below the knee had pursued compensation for her son
because she was certain that she must have received
thalidomide during her pregnancy. The German manufacturer of thalidomide refused compensation, claiming that thalidomide had never been distributed in the
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Azores. The mother fervently believed that thalidomide
was responsible for her son’s malformations and asked for
a further opinion. Review of the radiographs of his hips
and legs and reports of his complete evaluation performed at the local hospital in the Azores revealed no
other stigmata of thalidomide embryopathy (preaxial
limb defects, phocomelia, facial hemangioma, ear malformations, deafness, crocodile tears, ventricular septal
defect, intestinal or gall bladder atresia, kidney malformations). Most importantly, his limb malformations
were not of the thalidomide type. He had a unilateral
congenital amputation, with no digital remnants at the
end of the limb. His pelvis girdle was completely normal,
which would be unusual in a thalidomide-malformed
limb. Finally, his limb defect involved only one leg; the
other leg was completely normal, a finding that is very
unusual in a true thalidomide embryopathy. The young
man had a congenital amputation, probably due to
vascular disruption, cause unknown. Known causes of
vascular disruptive malformations are placental emboli,
cocaine or misoprostol exposure, and chorionic villous
sampling.
Patient 6. A family claimed that the antinausea medication bendectin, taken by the mother of a malformed boy,
was responsible for her son’s congenital limb reduction
defects. The mother took the medication after the period of
limb organogenesis, but some limb malformations can be
produced by environmental insults later in pregnancy. The
malformation was unaccompanied by any other dysmorphogenetic effects. The boy’s malformation was the classic
split-hand, split-foot syndrome, which is inherited dominantly. In a significant portion of cases, this malformation
is due to a new mutation. Because neither parent manifested the malformation, the logical conclusion was that
a new mutation had occurred in the sex cell of one of the
parents. Therefore, the risk of this malformation occurring in the offspring of this boy would be 50%. Bendectin
obviously was not responsible for this child’s malformations. In spite of the obvious genetic cause of the malformed child’s birth defects, a legal suit was filed, and a
jury decided that bendectin was not responsible for the
child’s birth defects.
Patient 7. A woman visited the emergency department of a university hospital complaining of severe lower
abdominal pain. An obstetric resident saw her because
she informed the staff that she had experienced a previous
ectopic pregnancy that necessitated the removal of one
ovary and tube. A pregnancy test was positive, and she
was scheduled to return to the obstetric clinic in 1 week.
At that time, her chorionic gonadotropin assessment was
repeated and had not changed from its previous value.

preventing congenital malformations

Without performing ultrasonography, ectopic pregnancy
was diagnosed. To preserve the patient’s reproductive
potential, it was decided to treat the ectopic pregnancy
with methotrexate rather than remove the remaining
tube and ovary. Following the administration of methotrexate, the patient was sent home, but a laboratory
report subsequently was received that indicated that the
gonadotropin value had increased fivefold; the laboratory report received earlier in the day was a copy of the
original report performed a week earlier. The patient
was called back to the hospital, and ultrasonography
revealed a normally implanted embryo. The senior obstetric staff counseled the mother that the baby was at
increased risk for CMs because of the exposure. The
patient refused to abort the pregnancy. The obstetric
department offered to provide care for the pregnancy
and delivery that included serial ultrasonography. At
28 weeks’ gestation, the patient went into labor and
delivered a liveborn preterm infant. During infancy,
hydrocephalus, developmental delay, and spastic cerebral
palsy were diagnosed. The family filed a lawsuit against
the doctors and the university hospital. The attorney
representing the child requested an evaluation of the
allegation that the child’s abnormalities were due to the
administration of the methotrexate. Methotrexate has
been reported to cause growth restriction, microcephaly,
developmental delay, and hydrocephalus but not prematurity. Review of the records revealed that ultrasonography performed 1 week before the preterm delivery showed
no evidence of hydrocephalus and that the birthweight
was appropriate for the gestational stage. The exposure to
methotrexate was not responsible for the serious problems
in this infant; the hydrocephalus and neurologic symptoms were due to an intracranial hemorrhage in the
postnatal period as a complication of the prematurity.
As these case reports indicate, determining the reproductive risks of an exposure during pregnancy or the
cause of a child’s CM is not a simple process. It involves
a careful analysis of the medical and scientific literature
pertaining to the reproductive toxic effects of exogenous
agents in humans and animals as well as an evaluation of
the exposure and biologic plausibility of an increased risk
or a causal connection between the exposure and a
child’s CM. Evaluation must include a careful physical
examination in addition to a review of the scientific
literature pertaining to genetic and environmental causes
of the malformations in question. Abridged counseling,
based on superficial and incomplete analyses, is a disservice to the family.
Pediatrics in Review Vol.32 No.10 October 2011 419
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Summary
• The development of new knowledge and new
diagnostic techniques and technology as well as the
sophistication of epidemiology studies and
maturation of the fields of clinical genetics and
clinical teratology have revolutionized the field of
reproductive and developmental biology.
• Advances have enabled physicians and scientists to
determine the causes of developmental
abnormalities and, therefore, discover methods of
prevention. The process of evaluation is based on
the knowledge base developed over the past 50
years.
• Although genetic abnormalities are responsible for a
significant proportion of reproductive and
developmental deleterious effects, a larger
proportion of these effects are due to unknown
causes.
• Environmental causes are less frequent, although
many of the environmental effects as well as many
of the genetic effects can be prevented through
genetic counseling and preconceptual planning.
Effective treatment and amelioration of
developmental effects also have improved.
• More than 50 environmental drugs, chemicals,
maternal diseases, infections, nutritional
abnormalities, and physical agents can affect
reproduction deleteriously and result in CMs.
Theoretically, all these causes are preventable.
• Throughout the developing world, the addition of
folic acid and iodine could prevent tens of
thousands of birth defects and developmental
abnormalities.
• In the United States, the opportunity for prevention
can be introduced at the population level and by
addressing individual patients’ clinical problems.
• If a mother of a malformed infant had some type of
exposure during pregnancy, such as a diagnostic
radiologic examination or medication, the consulting
physician should not support or suggest the
possibility of a causal relationship before performing
a complete evaluation. If a pregnant woman who
has not yet delivered had some type of exposure
during pregnancy, the consulting physician should
not support or suggest the possibility that the fetus
is at increased risk before performing a complete
evaluation. (11)(25)(26)(27)(28)(29)(30)
• Every patient deserves a complete, scholarly
evaluation that uses the basic principles of
teratology and risk analysis. (13)(14)24)
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PIR Quiz
Quiz also available online at http://pedsinreview.aappublications.org.
NOTE: Beginning in January 2012, learners will only be able to take Pediatrics in Review quizzes and claim credit
online. No paper answer form will be printed in the journal.
1. One of the principal advances in teratology over the past five decades is the discovery that:
A.
B.
C.
D.
E.

Exposure to teratogenic agents late in the second trimester may mar fetal development.
Most congenital malformations can be explained by exposure to teratogens.
Teratogenic syndromes cannot be confused with genetic mimics.
The effects of exposure to a teratogenic are independent of timing.
The effects of teratogenic agents are independent of dose.

2. Which of the following is a drug that has established teratogenic potential?
A.
B.
C.
D.
E.

Amlodipine.
Clonidine.
Hydrochlorothiazide.
Misoprostrol.
Metoproterenol.

3. Neural tube defects can be prevented best by assuring adequate folic acid and vitamin B-12 intake:
A.
B.
C.
D.
E.

Before pregnancy.
In pregnant women who have a family history of neural tube defects.
No later than the beginning of the second trimester.
Throughout the third trimester.
Upon diagnosis of pregnancy.

4. A fetus was exposed to radiation via radiotherapy of the mother’s breast cancer over a 5-week period
beginning at the 8th week of gestation. The infant at term is most likely to be:
A.
B.
C.
D.
E.

Deformed.
Large for age but otherwise normal.
Malformed.
Normal in all respects.
Small for age but otherwise normal.

5. An embryo was exposed at 7 days of gestation to radiation when the mother received a single abdominal
flat plate radiographic study to evaluate severe abdominal tenderness. The infant at term is most likely to
be:
A.
B.
C.
D.
E.

Deformed.
Large for age but otherwise normal.
Malformed.
Normal in all respects.
Small for age but otherwise normal.
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Things
Thi
ings You
Y N
Need To Know About Birth Defects
1. Did you know that birth defects are common?
Fact: Birth defects aﬀect 1 in 33 babies every year
and cause 1 in 5 infant deaths. For many babies
born with a birth defect, there is no family history
of the condition.

2. Did you know that a woman should take folic acid
during her teens and throughout her life?
Fact: Because half of all pregnancies in the United
States are not planned, all women who can become
pregnant should take a vitamin with folic acid every
day. Folic acid helps a baby’s brain and spine develop
very early in the ﬁrst month of pregnancy when a
woman might not know she is pregnant.

3. Did you know that many birth defects are
diagnosed after a baby leaves the hospital?
Fact: Many birth defects are not found
immediately at birth. A birth defect can aﬀect
how the body looks, how it works, or both. Some
birth defects like cleft lip or spina biﬁda are easy
to see. Others, like heart defects, are not.

4. Did you know that some birth defects can be
diagnosed before birth?
Fact: Tests like an ultrasound and amniocentesis can
detect birth defects such as spina biﬁda, heart defects,
or Down syndrome before a baby is born. Prenatal
care and screening are important because early
diagnosis allows families to make decisions and plan
for the future.

5. Did you know that birth defects can greatly aﬀect
the ﬁnances not only of the families involved,
but of everyone?
Fact: In the United States, birth defects have
accounted for over 139,000 hospital stays during a
single year, resulting in $2.5 billion in hospital costs
alone. Families and the government share the burden
of these costs. Additional costs due to lost wages or
occupational limitations can aﬀect families as well.
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6. Did you know that birth defects can be caused
by many diﬀerent things, not just genetics?
Fact: The cause of most birth defects is unknown. Use
of cigarettes, alcohol, and other drugs, taking of some
medicines; and exposure to chemicals and infectious
diseases during pregnancy have been linked to birth
defects. Researchers are studying the role of these
factors, as well as genetics, as causes of birth defects.

7. Did you know that some birth defects can
be prevented?
Fact: A woman can take some important steps
before and during pregnancy to help prevent birth
defects. She can take folic acid; have regular medical
checkups; make sure medical conditions, such as
diabetes, are under control; have tests for infectious
diseases and get necessary vaccinations; and not use
cigarettes, alcohol, or other drugs.

8. Did you know there are ways a pregnant woman
can keep her unborn baby safe from infections?
Fact: The best way to keep an unborn baby safe from
infections is for a pregnant woman to wash her hands
often, especially after using the bathroom; touching
raw meat, uncooked eggs, or unwashed vegetables;
handling pets; gardening; or caring for small children.

9. Did you know there is no known safe amount of
alcohol or safe time to drink during pregnancy?
Fact: Fetal alcohol spectrum disorders (FASDs) are a
group of conditions that can occur in a person whose
mother drank alcohol during pregnancy. These effects can include physical problems and problems
with behavior and learning which can last a lifetime.
There is no known safe amount, no safe time, and
no safe type of alcohol to drink during pregnancy.
FASDs are 100% preventable if a woman does not
drink alcohol while pregnant.

10. Did you know that an unborn child is not always
protected from the outside world?
Fact: The placenta, which attaches
a baby to the mother, is not a strong
barrier. When a mother uses cigarettes,
alcohol, or other drugs, or is exposed
to infectious diseases, her baby is
exposed also. Healthy habits like
taking folic acid daily and eating
nutritious foods can help ensure
that a child is born healthy.

To ﬁnd out more about birth defects and healthy pregnancies, please visit the
Centers for Disease Control and Prevention website
www.cdc. gov/pregnancy or call your state or local health department.
This fact sheet was developed in partnership with the National Birth Defects Prevention Network (NBDPN).
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